• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 19191
Device Problem Unintended Movement (3026)
Patient Problems Skin Irritation (2076); Caustic/Chemical Burns (2549)
Event Date 07/21/2019
Event Type  Injury  
Manufacturer Narrative
The device was not returned for evaluation.We are unable to determine if any product condition could have contributed to the skin irritation/chemical burn.Lot release and sterilization records were reviewed and the product lot met all acceptance criteria.Omnipod insulin management system ¿ user guide.Model: ust400.17845-5a-aw rev b 09/17.Changing your pod.Chapter 3 / page 23.Warnings: do not use a pod if you are sensitive to or have allergies to acrylic adhesives, or have fragile or easily damaged skin.If you are a first-time omnipod system user, your omnipod system trainer will guide you through the steps for initializing and applying your first pod.Do not attempt to apply or use a pod until you have been trained by your omnipod system trainer.Use of the system with inadequate training or improper setup could put your health and safety at risk.Living with diabetes.Chapter 11 / page 115.Infusion site checks.At least once a day, use the pod's viewing window to inspect the infusion site.Check the site for: leakage or scent of insulin, which may indicate the cannula has dislodged.Signs of infection, such as pain, swelling, redness, discharge or heat.
 
Event Description
The patient report that at around 4 am, she woke up to feeling a wetness on her skin where the pod was on her abdomen.She believes that the cannula dislodged from her skin when she was sleeping.Her blood glucose reached 245mg/dl.She went to the urgent care later in the morning.Once there, the patient was diagnosed with a chemical burn that went through the dermis layer of her skin and into the epidermis.The pa (physician assistant) prescribed silvadene usp 1% cream to apply twice daily.Other instructions for care were to keep the area clean, dry, and covered by a (b)(6); as well as to watch for signs of infection.If the customer were to see increased redness, streaks, or discharge indicating a potential infection, she is to see her primary care doctor or return to the clinic immediately.The pod was worn longer than 48 hours.
 
Manufacturer Narrative
The received device had the cannula assembly deployed.The downloaded data returned an alarm, indicating that a communication error occurred while the device was waiting for input from the pdm.Inspection of the device found no evidence that would result in skin irritation occurring at the infusion site; a root cause could not be determined.No evidence was found that would result in the cannula dislodging; a root cause could not be determined.No leaks in the fluid path were found.No evidence was found that would result in a communication error occurring; a root cause could not be determined.No other defects or deficiencies were found that would result in a failure of the device to deliver insulin.(device available for eval: yes, date returned to mfg: 8/5/2019) the device had been received at the time of initial report.(device returned to manufacturer? yes) the device had been returned to the manufacturer at the time of initial report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
600 technology park drive
suite 200
billerica MA 01821
Manufacturer (Section G)
INSULET CORPORATION
600 technology park drive
suite 200
billerica MA 01821
Manufacturer Contact
derek sammarco
600 technology park drive
suite 200
billerica, MA 01821
9786007000
MDR Report Key8873487
MDR Text Key153658896
Report Number3004464228-2019-07354
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385081120033
UDI-Public(01)20385081120033(11)190316(17)200916(10)L44676
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162296
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/16/2020
Device Model Number19191
Device Catalogue NumberZXP425
Device Lot NumberL44676
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/05/2019
Is the Reporter a Health Professional? No
Date Manufacturer Received09/12/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/16/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age51 YR
-
-